查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442913

血管成形术球囊支架 - 全球市场回顾、竞争格局、市场预测 (2030)

Angioplasty Balloons And Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计 2024 年至 2030 年预测期内，全球血管成形术球囊和支架市场规模将以 3.67% 的复合年增长率成长。对血管成形术球囊支架的需求主要是由于心血管疾病（CVD）患者数量的增加、对微创手术的需求不断增加以及药物涂层/药物洗脱球囊的不断创新所推动的。此外，由于该领域正在进行的大量研究活动以及医疗保健提供者、研究人员、行业参与者等之间的联盟和战略伙伴关係，血管成形术球囊支架市场预计将增长。预计将在预测期内为整体市场成长做出贡献~2030。

血管成形术球囊支架的市场动态

根据American Heart Association（2022）的数据，2020年全球约有2.441亿人患有冠状动脉心臟病（缺血性心臟病）。

根据British Heart Foundation（2022）的数据，2019 年全球约有5.5 亿人（每14 人中就有1 人）患有心臟和循环系统疾病，其中约2.9 亿人包括1 万名女性和约2.6 亿男性。据同一消息来源称，2019年，北美有4,103,135人被诊断出患有心血管疾病，1,089,947人被诊断出患有冠状动脉疾病，498,551人被诊断出患有中风，亚洲有32,376,834人被诊断出患有心血管疾病，其中12,543,833人患有心血管疾病。冠状动脉疾病和 8,111,044 人患有中风。

文件进一步指出，冠状动脉心臟病、週边动脉疾病、中风和心房颤动仍是2019年全球最常见且流行的心血管疾病。

越来越多的危险因子导致心血管疾病的发展，如肥胖、高血压、糖尿病、吸烟、老年、饮酒、不健康的生活习惯和动脉粥状硬化，这会进一步加速推动血管成形术球囊支架市场的发展。

根据世界卫生组织（2022）提供的数据，2020年，全球约有10亿人年龄在60岁或以上。到2050年，60岁及以上的老年人口预计将增加一倍，达到约21亿人。

研究表明，PAD 的盛行率随着年龄的增长而增加，影响 60 岁以下人群的 3%，但 70 岁以上人口的盛行率则增至 15% 至 20%。

因此，由于上述因素，血管成形术球囊支架市场预计将在预测期内成长。

然而，严格的监管程序和产品召回造成的不利影响可能会抑制血管成形术球囊支架市场的整体成长。

血管成形术球囊和支架市场细分分析

在血管成形术球囊和支架市场的球囊类别的产品类型部分，药物涂层球囊预计将在 2023 年占重要的收入占有率。

药物涂层球囊在治疗冠状动脉疾病和周边动脉疾病的益处和应用预计将增加其需求。

药物涂层球囊（DCB）血管成形术在程序上与传统球囊血管成形术（POAB）相同，但球囊上涂有抗增殖药物和赋形剂以增强药物输送。

药物涂层球囊有助于预防再狭窄。使用药物涂层球囊可以抑制细胞分裂并减少治疗后再狭窄或闭塞再生的程度。

DCB血管成形术中不会植入异物，患者的身体不仅不会改变冠状动脉原有的解剖结构，也不会产生晚期支架血栓和过敏等风险。

此外，它还提供了进一步手术和介入治疗的可能性，特别是对于年轻患者。

本报告提供了全球血管成形球囊和支架市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章血管成形术球囊支架市场报告简介

第二章血管成形术球囊与支架市场概要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章血管成形术球囊支架市场关键因素分析

  • 血管成形术球囊和支架市场的驱动因素
  • 血管成形术球囊和支架市场的限制因素和挑战
  • 血管成形术球囊和支架市场的机会

第五章血管成形球囊和支架市场的波特五力分析

第六章血管成形术球囊支架市场布局

  • 产品类别
  • 气球
    • 药物涂层球囊
    • 常规气球
  • 支架
    • 药物洗脱支架
    • 裸金属支架
  • 依指示
    • 冠状动脉疾病
    • 外周动脉疾病
  • 依最终用户
    • 医院
    • 门诊手术中心
    • 导管实验室
  • 区域
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第 7 章：血管成形术球囊支架市场公司与产品概况

  • B. Braun SE
  • BIOTRONIK
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Cook
  • Biosensors International Group, Ltd.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • BD
  • Demax Medical Technology
  • BrosMed Medical Co., Ltd.
  • Cordis
  • Sino Medical Sciences Technology Inc.
  • Concept Medical

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明，联络我们

Product Code: DIMDCL0699

The Angioplasty Balloons And Stents Market By Product Type (Balloons [Drug-Coated Balloons And Plain Old Balloons], Stents [Drug-Eluting Stents And Bare Metal Stents]), Indication (Coronary Artery Disease And Peripheral Artery Disease), End-User (Hospitals, Ambulatory Surgical Centers, And Cath Labs), and geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing number of cases of urinary tract infections (UTI) and increasing research and development activities

The global angioplasty balloons and stents market is estimated to grow at a CAGR of 3.67% during the forecast period from 2024 to 2030. The demand for angioplasty balloons and stents is primarily being boosted by the increasing number of people with cardiovascular diseases (CVDs), the rise in demand for minimally invasive procedures, growing innovations in drug-coated/drug-eluting balloons, and others. Furthermore, the angioplasty balloons and stents market is anticipated to grow on account of a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the angioplasty balloons and stents market during the forecast period from 2024-2030.

Angioplasty Balloons And Stents Market Dynamics:

According to American Heart Association 2022 data, globally about 244.1 million people were living with coronary (ischemic) heart disease in 2020.

As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men. As per the same source, in 2019, in North America, cardiovascular diseases affected 4,103,135 people, 1,089,947 people were diagnosed with coronary artery disease, and 498,551 suffered from stroke; In Asia, there were 32,376,834 people diagnosed with cardiovascular diseases, from which 12,543,833 individuals were affected by coronary artery disease, and 8,111,044 population was suffered from a stroke.

The source mentioned above further stated that coronary (ischemic) heart disease (200 million cases), peripheral arterial (vascular) disease (110 million cases), stroke (100 million cases), and atrial fibrillation (60 million cases) remained the commonest and prevalent cardiovascular conditions worldwide in 2019.

The increasing number of risk factors such as obesity, hypertension, diabetes, smoking, old age, alcohol consumption, unhealthy lifestyle, atherosclerosis, and others causing the development of cardiovascular diseases in one way or another are further going to accelerate the market for angioplasty balloons and stents.

According to the data provided by the WHO (2022), in 2020, about one billion people across the world were over the age of 60. The source mentioned above added by stating that by 2050, the elderly population aged 60 and above is expected to double in number representing about 2.1 billion people.

As per research studies, the prevalence of PAD increases with age; it occurs in 3% of people <60 years, but its prevalence increases to 15% to 20% among individuals >70 years.

Thus, owing to the above-mentioned factors, the angioplasty balloons and stents market is estimated to grow during the forecast period.

However, stringent regulatory procedures adverse effects, and product recalls may restrict the growth of the overall angioplasty balloons and stents market.

Angioplasty Balloons And Stents Market Segment Analysis:

Angioplasty Balloons and Stents Market By Product Type (Balloons [Drug-Coated Balloons and Plain Old Balloons], Stents [Drug-Eluting Stents and Bare Metal Stents]), Indication (Coronary Artery Disease and Peripheral Artery Disease), End-User (Hospitals, Ambulatory Surgical Centers, and Cath Labs), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment under the balloons category of the Angioplasty Balloons and Stents market, the drug-coated balloons, category is expected to amass a significant revenue share in the year 2023.

The advantages and applications associated with drug-coated balloons in the treatment of coronary artery disease and peripheral artery disease are going to increase their demand.

Procedure-wise, Drug-Coated Balloon (DCB) angioplasty is comparable to Plain Old Balloon Angioplasty (POAB), but it includes coating the balloon with an anti-proliferative medicine and an excipient to facilitate drug transfer.

Drug-coated balloons aid in the prevention of restenosis, which is the vessel's re-narrowing at a previously treated spot. Employing a balloon coated with medication may prevent cell division, thereby reducing the degree of restenosis, or blockage regrowth, following therapy.

By not implanting a foreign body during the DCB angioplasty, the patient's body is spared from modifications to the coronary artery's original anatomical structure as well as risks such as late stent thrombosis and allergy.

Additionally, it offers chances for further surgical treatment or interventional therapy, especially for young patients.

The interventional process is comparatively easy, requiring less time to complete and exposing patients and medical personnel to less radiation.

By uniformly distributing the medication to the blood vessel's inner wall, DCB can prevent the delayed endothelialization brought on by the unequal dispersion of stent metal rods.

By applying DCB, the duration of dual antiplatelet medication can be shortened, and the risk of bleeding and other problems can be decreased.

For certain kinds of lesions, such as narrow lesions, high bleeding risk lesions, patients with diabetes, etc., DCB may be a better option than stent insertion.

Thus, all the above-mentioned factors are likely to propel the market for drug-coated balloons in Angioplasty Balloons and Stents.

North America is expected to dominate the overall Angioplasty Balloons And Stents Market:

Among all the regions, North America is estimated to account for the largest share of the Angioplasty Balloons and Stents market in the year 2023. This domination is due to the increasing application of angioplasty balloons and stents in the treatment and management of peripheral and coronary artery disease which are on the rise in the region, increasing sedentary lifestyle, anxiety, and stress resulting in chronic diseases, such as diabetes and obesity, leading to an increase in the prevalence of multiple cardiovascular diseases, rising product launch and approvals, presence of favorable regulatory authority, among others will propel the market of angioplasty balloons and stents in the US.

For instance, as per the study conducted by the Centre for Disease Control and Prevention (CDC) in 2023, it was stated that in 2021, about 1 in 20 adults age 20 and older have coronary artery disease (CAD). Coronary heart disease is the most common type of heart disease in the US, killing 375,476 people in 2021. In 2021, about 2 in 10 deaths from CAD happened in adults less than 65 years old. Thus, the high burden of cardiovascular diseases in the region demands the availability of drug-eluting balloons.

The American Heart Association in the latest study estimated that over 500,000 percutaneous coronary intervention (PCI) procedures are carried out annually in the US. Percutaneous coronary intervention with a drug-coated balloon (DCB) is a novel treatment that seeks to acutely dilate coronary stenosis and deliver an anti-proliferative drug to the vessel wall. Thus, the number of PCI procedures in the region will increase the demand for drug-eluting balloons.

Further, the availability of various major manufacturers, the launch and approval of new and technologically advanced devices, and favorable reimbursement regulations are all important factors responsible for driving the demand for drug-eluting balloons in the region. For instance, in November 2022, Genesis MedTech Group announced that the Food and Drug Administration (FDA) has approved the Chocolate Touch(R) Drug-coated Balloon PTA Catheter, developed by TriReme Medical LLC, for the treatment of patients with peripheral artery disease in the superficial femoral artery and the popliteal artery.

Thus, the above-mentioned factors are likely to propel the growth of the angioplasty balloons and stents market in the region during the forecast period from 2024-2030.

Angioplasty Balloons And Stents Market Key Players:

Some of the key market players operating in the Angioplasty Balloons and Stents market include B. Braun SE, BIOTRONIK, Medtronic, Abbott, Boston Scientific Corporation, Cook, Biosensors International Group, Ltd., MicroPort Scientific Corporation, Terumo Corporation, Demax Medical Technology, BD, BrosMed Medical Co., Ltd., Cordis, Sino Medical Sciences Technology Inc., Concept Medical, and Others.

Recent Developmental Activities in the Angioplasty Balloons And Stents Market:

  • In January 2023, The US Food and Drug Administration (FDA) approved the Stellarex 0.035" OTW Drug-coated Angioplasty Balloon - P160049/S015, from Philips Image Guided Therapy Corp.
  • In August 2019, B. Braun Interventional Systems Inc. (BIS) announced that the US Food and Drug Administration (FDA) granted Breakthrough Device Designation for the SeQuent Please ReX drug-coated PTCA balloon catheter.

Key Takeaways from the Angioplasty Balloons And Stents Market Report Study

  • Market size analysis for current angioplasty balloons and stents market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Angioplasty Balloons and Stents market.
  • Various opportunities available for the other competitors in the Angioplasty Balloons and Stents market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Angioplasty Balloons and Stents market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Angioplasty Balloons and Stents market growth in the coming future?

Target Audience who can be benefited from this Angioplasty Balloons And Stents Market Report Study

  • Angioplasty Balloons and stent product providers
  • Research organizations and consulting companies
  • Angioplasty Balloons and Stents-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Angioplasty Balloons and Stents
  • Various End-users who want to know more about the Angioplasty Balloons and Stents market and the latest developments in the Angioplasty Balloons and Stents market.

Frequently Asked Questions for the Angioplasty Balloons And Stents Market:

1. What are angioplasty balloons and stents?

Angioplasty Balloons and Stents are intended for the effective treatment of coronary and peripheral artery disease by opening a narrowed or blocked artery.

2. What is the market for global Angioplasty Balloons and Stents?

The global angioplasty balloons and stents market is estimated to grow at a CAGR of 3.67% during the forecast period from 2024 to 2030.

3. What are the drivers for the global angioplasty balloons and stents market?

The demand for angioplasty balloons and stents is primarily being boosted by the increasing number of people with cardiovascular diseases (CVDs), the rise in demand for minimally invasive procedures, growing innovations in drug-coated/drug-eluting balloons, and others. Furthermore, the angioplasty balloons and stents market is anticipated to grow on account of a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the angioplasty balloons and stents market during the forecast period from 2024-2030.

4. Who are the key players operating in the global angioplasty balloons and stents market?

Some of the key market players operating in the angioplasty balloons and stents market include B. Braun SE, BIOTRONIK, Medtronic, Abbott, Boston Scientific Corporation, Cook, Biosensors International Group, Ltd., MicroPort Scientific Corporation, Terumo Corporation, Demax Medical Technology, BD, BrosMed Medical Co., Ltd., Cordis, Sino Medical Sciences Technology Inc., Concept Medical, and Others.

5. Which region has the highest share in the angioplasty balloons and stents market?

North America is expected to dominate the overall Angioplasty Balloons and Stents market during the forecast period from 2024-2030. Owing to the significance of key growth factors such as the increasing patient pool with peripheral and coronary artery disease, increasing sedentary lifestyle, anxiety, and stress resulting in chronic diseases, such as diabetes and obesity, leading to an increase in the prevalence of multiple cardiovascular diseases. Further, rising product launches and approvals and, the presence of favorable regulatory authority, among others will propel the market of angioplasty balloons and stents in the US.

Table of Contents

1. Angioplasty Balloons and Stents Market Report Introduction

2. Angioplasty Balloons and Stents Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Angioplasty Balloons and Stents Market Key Factors Analysis

  • 4.1. Angioplasty Balloons and Stents Market Drivers
    • 4.1.1. The rising burden of cardiovascular diseases (CVDs) and its risk factors
    • 4.1.2. Growing technological advancement in the product portfolio
    • 4.1.3. Growing preference for minimally invasive procedures
  • 4.2. Angioplasty Balloons and Stents Market Restraints and Challenges
    • 4.2.1. Inherent complications with angioplasty procedures
    • 4.2.2. Compliance and regulatory pressures
  • 4.3. Angioplasty Balloons and Stents Market Opportunities
    • 4.3.1. Medical device expansion in developing regions coupled with government initiatives
    • 4.3.2. Increasing research and development activities w.r.t. angioplasty balloons and stents

5. Angioplasty Balloons and Stents Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Angioplasty Balloons and Stents Market Layout

  • 6.1. By Product Type
  • 6.2. Balloons
    • 6.2.1. Drug-Coated Balloons
    • 6.2.2. Plain Old Balloons
  • 6.3. Stents
    • 6.3.1. Drug-eluting Stents
    • 6.3.2. Bare Metal Stents
  • 6.4. By Indication
    • 6.4.1. Coronary Artery Disease
    • 6.4.2. Peripheral Artery Disease
  • 6.5. By End-User
    • 6.5.1. Hospitals
    • 6.5.2. Ambulatory Surgical Centers
    • 6.5.3. Cath Labs
  • 6.6. By Geography
    • 6.6.1. North America
      • 6.6.1.1. United States Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.1.2. Canada Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.1.3. Mexico Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.2. Europe
      • 6.6.2.1. France Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.2.2. Germany Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.2.3. United Kingdom Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.2.4. Italy Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.2.5. Spain Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.2.6. Rest of Europe Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.3. Asia-Pacific
      • 6.6.3.1. China Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.3.2. Japan Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.3.3. India Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.3.4. Australia Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.3.5. South Korea Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.3.6. Rest of Asia-Pacific Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
    • 6.6.4. Rest of the World (RoW)
      • 6.6.4.1. Middle East Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.4.2. Africa Angioplasty Balloons and Stents Market Size in USD million (2021-2030)
      • 6.6.4.3. South America Angioplasty Balloons and Stents Market Size in USD million (2021-2030)

7. Angioplasty Balloons and Stents Market Company and Product Profiles

  • 7.1. B. Braun SE
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. BIOTRONIK
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Medtronic
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Abbott
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Boston Scientific Corporation
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Cook
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Biosensors International Group, Ltd.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. MicroPort Scientific Corporation
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Terumo Corporation
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. BD
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Demax Medical Technology
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. BrosMed Medical Co., Ltd.
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Cordis
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Sino Medical Sciences Technology Inc.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Concept Medical
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Angioplasty Balloons and Stents Market in Global (2021-2030)
  • Table 3: Angioplasty Balloons and Stents Market in Global by Product Type (2021-2030)
  • Table 4: Angioplasty Balloons and Stents Market in Global by Indication (2021-2030)
  • Table 5: Angioplasty Balloons and Stents Market in Global by End-User (2021-2030)
  • Table 6: Angioplasty Balloons and Stents Market in Global by Geography (2021-2030)
  • Table 7: Angioplasty Balloons and Stents Market in North America (2021-2030)
  • Table 8: Angioplasty Balloons and Stents Market in the US (2021-2030)
  • Table 9: Angioplasty Balloons and Stents Market in Canada (2021-2030)
  • Table 10: Angioplasty Balloons and Stents Market in Mexico (2021-2030)
  • Table 11: Angioplasty Balloons and Stents Market in Europe (2021-2030)
  • Table 12: Angioplasty Balloons and Stents Market in France (2021-2030)
  • Table 13: Angioplasty Balloons and Stents Market in Germany (2021-2030)
  • Table 14: Angioplasty Balloons and Stents Market in the United Kingdom (2021-2030)
  • Table 15: Angioplasty Balloons and Stents Market in Italy (2021-2030)
  • Table 16: Angioplasty Balloons and Stents Market in Spain (2021-2030)
  • Table 17: Angioplasty Balloons and Stents Market in the Rest of Europe (2021-2030)
  • Table 18: Angioplasty Balloons and Stents Market in Asia-Pacific (2021-2030)
  • Table 19: Angioplasty Balloons and Stents Market in China (2021-2030)
  • Table 20: Angioplasty Balloons and Stents Market in Japan (2021-2030)
  • Table 21: Angioplasty Balloons and Stents Market in India (2021-2030)
  • Table 22: Angioplasty Balloons and Stents Market in Australia (2021-2030)
  • Table 23: Angioplasty Balloons and Stents Market in South Korea (2021-2030)
  • Table 24: Angioplasty Balloons and Stents Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Angioplasty Balloons and Stents Market in the Rest of the World (2021-2030)
  • Table 26: Angioplasty Balloons and Stents Market in the Middle East (2021-2030)
  • Table 27: Angioplasty Balloons and Stents Market in Africa (2021-2030)
  • Table 28: Angioplasty Balloons and Stents Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Angioplasty Balloons and Stents Market in Global (2021-2030)
  • Figure 3: Angioplasty Balloons and Stents Market in Global by Product Type (2021-2030)
  • Figure 4: Angioplasty Balloons and Stents Market in Global by Indication (2021-2030)
  • Figure 5: Angioplasty Balloons and Stents Market in Global by End-User (2021-2030)
  • Figure 6: Angioplasty Balloons and Stents Market in Global by Geography (2021-2030)
  • Figure 7: Angioplasty Balloons and Stents Market in North America (2021-2030)
  • Figure 8: Angioplasty Balloons and Stents Market in the US (2021-2030)
  • Figure 9: Angioplasty Balloons and Stents Market in Canada (2021-2030)
  • Figure 10: Angioplasty Balloons and Stents Market in Mexico (2021-2030)
  • Figure 11: Angioplasty Balloons and Stents Market in Europe (2021-2030)
  • Figure 12: Angioplasty Balloons and Stents Market in France (2021-2030)
  • Figure 13: Angioplasty Balloons and Stents Market in Germany (2021-2030)
  • Figure 14: Angioplasty Balloons and Stents Market in the United Kingdom (2021-2030)
  • Figure 15: Angioplasty Balloons and Stents Market in Italy (2021-2030)
  • Figure 16: Angioplasty Balloons and Stents Market in Spain (2021-2030)
  • Figure 17: Angioplasty Balloons and Stents Market in the Rest of Europe (2021-2030)
  • Figure 18: Angioplasty Balloons and Stents Market in Asia-Pacific (2021-2030)
  • Figure 19: Angioplasty Balloons and Stents Market in China (2021-2030)
  • Figure 20: Angioplasty Balloons and Stents Market in Japan (2021-2030)
  • Figure 21: Angioplasty Balloons and Stents Market in India (2021-2030)
  • Figure 22: Angioplasty Balloons and Stents Market in Australia (2021-2030)
  • Figure 23: Angioplasty Balloons and Stents Market in South Korea (2021-2030)
  • Figure 24: Angioplasty Balloons and Stents Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Angioplasty Balloons and Stents Market in the Rest of the World (2021-2030)
  • Figure 26: Angioplasty Balloons and Stents Market in the Middle East (2021-2030)
  • Figure 27: Angioplasty Balloons and Stents Market in Africa (2021-2030)
  • Figure 28: Angioplasty Balloons and Stents Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis